Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Hazard Rate01:11

Hazard Rate

104
The hazard rate, also known as the hazard function or failure rate, is a statistical measure used to describe the instantaneous rate at which an event occurs, given that the event has not yet happened. From a probabilistic perspective, it represents the likelihood that a subject will experience the event in a very small time interval, conditional on surviving up to the beginning of that interval. In terms of frequency, the hazard rate can be viewed as the ratio of the number of events to the...
104
Assumptions of Survival Analysis01:15

Assumptions of Survival Analysis

123
Survival models analyze the time until one or more events occur, such as death in biological organisms or failure in mechanical systems. These models are widely used across fields like medicine, biology, engineering, and public health to study time-to-event phenomena. To ensure accurate results, survival analysis relies on key assumptions and careful study design.
123
Comparing the Survival Analysis of Two or More Groups01:20

Comparing the Survival Analysis of Two or More Groups

177
Survival analysis is a cornerstone of medical research, used to evaluate the time until an event of interest occurs, such as death, disease recurrence, or recovery. Unlike standard statistical methods, survival analysis is particularly adept at handling censored data—instances where the event has not occurred for some participants by the end of the study or remains unobserved. To address these unique challenges, specialized techniques like the Kaplan-Meier estimator, log-rank test, and...
177
The Mantel-Cox Log-Rank Test01:19

The Mantel-Cox Log-Rank Test

351
The Mantel-Cox log-rank test is a widely used statistical method for comparing the survival distributions of two groups. It tests whether a statistically significant difference exists in survival times between the groups without assuming a specific distribution for the survival data, making it a non-parametric test. This flexibility makes the log-rank test particularly valuable in medical research and other fields where the timing of an event, such as death or disease recurrence, is of...
351
Hazard Ratio01:12

Hazard Ratio

114
The hazard ratio (HR) is a widely used measure in clinical trials to compare the risk of events, such as death or disease recurrence, between two groups over time. It reflects the ratio of hazard rates—the instantaneous risk of the event occurring—between a treatment group and a control group. This measure provides valuable insights into the relative effectiveness of a treatment by assessing how the risk of an event differs between the two groups.
For example, in a clinical trial...
114
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches01:23

Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches

125
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
125

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Use of a polygenic risk score to enhance early detection of coronary atherosclerosis.

American journal of preventive cardiology·2026
Same author

Wqsreg: a Stata command for weighted quantile sum regression.

European journal of epidemiology·2026
Same author

Total Event Analysis in Cardiovascular Outcome Trials: Approaches and Interpretation.

Circulation·2026
Same author

Effects of SGLT2 inhibition on incident heart failure in carriers of cardiomyopathy-associated genetic variants.

Nature medicine·2026
Same author

Evolocumab in Patients With High-Risk Diabetes: Results From the VESALIUS-CV Trial.

Diabetes care·2026
Same author

Lipoprotein(a) Levels, Risk of Cardiovascular Events, and Benefit of Evolocumab: Findings From the VESALIUS-CV Trial.

Circulation·2026

Related Experiment Video

Updated: Jun 25, 2025

An R-Based Landscape Validation of a Competing Risk Model
05:37

An R-Based Landscape Validation of a Competing Risk Model

Published on: September 16, 2022

2.0K

Estimating and presenting hazard ratios and absolute risks from a Cox model with complex nonlinear interactions.

Andrea Bellavia1, Giorgio E M Melloni1, Jeong-Gun Park1

  • 1TIMI Study Group, Division of Cardiovascular Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA 02115, United States.

American Journal of Epidemiology
|May 22, 2024
PubMed
Summary

This study introduces a new method for analyzing interactions in survival data, improving precision health research. It enables more accurate assessment of how multiple factors affect clinical outcomes on both multiplicative and additive scales.

Keywords:
Cox regressioninteractionsplinessurvival analysis

More Related Videos

Establishing a Competing Risk Regression Nomogram Model for Survival Data
04:57

Establishing a Competing Risk Regression Nomogram Model for Survival Data

Published on: October 23, 2020

10.1K
Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery
06:46

Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery

Published on: September 27, 2024

252

Related Experiment Videos

Last Updated: Jun 25, 2025

An R-Based Landscape Validation of a Competing Risk Model
05:37

An R-Based Landscape Validation of a Competing Risk Model

Published on: September 16, 2022

2.0K
Establishing a Competing Risk Regression Nomogram Model for Survival Data
04:57

Establishing a Competing Risk Regression Nomogram Model for Survival Data

Published on: October 23, 2020

10.1K
Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery
06:46

Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery

Published on: September 27, 2024

252

Area of Science:

  • Biostatistics
  • Epidemiology
  • Clinical Research

Background:

  • Interaction analysis is crucial in clinical and public health research for precision medicine.
  • Current methods often oversimplify interactions, limiting precision and information, especially in time-to-event analysis.
  • Existing approaches typically focus on multiplicative scales, ignoring clinically relevant absolute risk information.

Purpose of the Study:

  • To present a user-friendly procedure for estimating and presenting interactive effects in survival analysis.
  • To enable assessment of interactions on both multiplicative and additive scales.
  • To facilitate flexible incorporation of nonlinear interactions with continuous covariates.

Main Methods:

  • Utilizing individual absolute risk predictions from Cox models.
  • Developing a procedure for flexible interaction assessment with continuous covariates.
  • Providing software for replication and discussing confidence interval derivation.

Main Results:

  • The proposed method allows for a more precise estimation of interactive effects.
  • It enables the presentation of results on both multiplicative and additive scales.
  • The approach accommodates nonlinear interactions with continuous covariates.

Conclusions:

  • The new procedure enhances the assessment of complex covariate relationships in survival analysis.
  • It offers a more intuitive and precise depiction of interaction and effect stratification results.
  • This facilitates better understanding of clinical endpoints in public health and clinical research.